ZENURA

Janssen Sciences Ireland UC

Application Filed: 2018-03-29

Trademark Application Details

Status

730

Live/Pending

FIRST EXTENSION - GRANTED

Research	OneLook Acronym Finder
Serial Number	87855503
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Cheryl L. Foytlin
Attorney Docket Number	T33537US3
Law Office Assigned	L60
Employee Name	MUCHA, JOHN EVAN

Timeline

2018-03-29	Application Filed
2018-07-31	Published for Opposition
2019-06-25	Location: INTENT TO USE SECTION
2019-11-18	Status: Live/Pending
2019-11-20	Transaction Date

Trademark Applicants & Owners

Owner:	Janssen Sciences Ireland UC
Entity Statement	PRIVATE UNLIMITED LIABILITY COMPANY
Address	Eastgate Village, Eastgate Little Island County Cork IE
Legal Entity Type
Legal Entity State	IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Cheryl L. Foytlin
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK NJ 08933

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, cerebrovascular diseases, and viral diseases excluding antivirals for the treatment of liver disease and HIV infection; vaccines; anxiolytics; anti-allergics; anti-infectives

Type Code

Type

GS0051

Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, cerebrovascular diseases, and viral diseases excluding antivirals for the treatment of liver disease and HIV infection; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2018-04-02	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-04-05	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2018-06-11	3 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN	2018-06-12	4 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2018-06-12	5 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2018-06-12	6 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2018-06-12	7 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-06-12	8 CNSA P:
ASSIGNED TO LIE	2018-06-20	9 ALIE A:Allowance for Publication
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-07-11	10 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2018-07-31	11 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2018-07-31	12 NPUB E:E-Mail
EXTENSION OF TIME TO OPPOSE RECEIVED	2018-08-24	13 ETOF T:TTAB Proceeding
OPPOSITION INSTITUTED NO. 999999	2018-11-26	14 OP.I T:TTAB Proceeding
OPPOSITION DISMISSED NO. 999999	2019-05-10	15 OP.D T:TTAB Proceeding
OPPOSITION TERMINATED NO. 999999	2019-05-10	16 OP.T T:TTAB Proceeding
TTAB RELEASE CASE TO TRADEMARKS	2019-05-10	17 TMBN T:TTAB Proceeding
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2019-06-25	18 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2019-11-18	19 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2019-11-18	20 EXT1 S:
EXTENSION 1 GRANTED	2019-11-18	21 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-11-20	22 EXRA E:E-Mail
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2020-03-18	23 ASGN I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2020-06-17	24 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2020-06-17	25 EXT2 S:
EXTENSION 2 GRANTED	2020-06-17	26 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-06-19	27 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2020-12-03	28 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2020-12-03	29 EXT3 S:
EXTENSION 3 GRANTED	2020-12-03	30 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-12-05	31 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2021-06-10	32 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2021-06-10	33 EXT4 S:
EXTENSION 4 GRANTED	2021-06-10	34 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2021-06-12	35 EXRA E:E-Mail
ASSIGNED TO EXAMINER	2021-11-10	36 DOCK D:Assigned to Examiner
TEAS EXTENSION RECEIVED	2021-12-01	37 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2021-12-10	38 AITU A:Allowance for Publication
EXTENSION 5 FILED	2021-12-01	39 EXT5 S:
EXTENSION 5 GRANTED	2021-12-10	40 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2021-12-11	41 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2022-08-01	42 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2022-08-01	43 MAB6 E:E-Mail

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ZENURA 98128185 not registered Live/Pending	KACHING GROUP INTERNATIONAL JOINT STOCKCOMPANY 2023-08-11
ZENURA 87855503 not registered Live/Pending	Janssen Sciences Ireland UC 2018-03-29
ZENURA 86411164 not registered Dead/Abandoned	JANSSEN SCIENCES IRELAND UC 2014-10-01
ZENURA 85283621 not registered Dead/Abandoned	JANSSEN R&D IRELAND 2011-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.